50 related articles for article (PubMed ID: 20090368)
1. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M
BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
[TBL] [Abstract][Full Text] [Related]
3. The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review.
Liu H; Luo C; Li Z; Zhang C; Xiong J
J Nephrol; 2023 Apr; 36(3):663-667. PubMed ID: 36370330
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
Katsarou M; Stratikos E; Chroni A
J Lipid Res; 2018 Dec; 59(12):2339-2348. PubMed ID: 30309894
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.
Tanimizu H; Hara R; Sekine A; Inoue N; Hasegawa E; Tanaka K; Kono K; Kinowaki K; Ohashi K; Okubo M; Yamaguchi Y; Kang D; Honda K; Saito T; Sawa N; Ubara Y; Hoshino J
Intern Med; 2023; 62(15):2209-2214. PubMed ID: 37532513
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein glomerulopathy: a rare cause of steroid-resistant nephrotic syndrome in a child.
Vala K; Shah K; Kapadia S; Khandelwal M; Jojera A; Soni S; Prajapati A; Saha A
CEN Case Rep; 2024 Mar; ():. PubMed ID: 38438730
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein Glomerulopathy, First Case Report from Canada.
Ting JA; McRae SA; Schwartz D; Barbour SJ; Riazy M
Int J Nephrol Renovasc Dis; 2022; 15():207-214. PubMed ID: 35761986
[TBL] [Abstract][Full Text] [Related]
9. An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.
Li MS; Li Y; Liu Y; Zhou XJ; Zhang H
Front Med (Lausanne); 2022; 9():905007. PubMed ID: 35602473
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
Yang M; Weng Q; Pan X; Hussain HMJ; Yu S; Xu J; Yu X; Liu Y; Jin Y; Zhang C; Li X; Ren H; Chen N; Xie J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1281. PubMed ID: 32441489
[TBL] [Abstract][Full Text] [Related]
11. Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.
Takasaki S; Maeda K; Joh K; Yamakage S; Fukase S; Takahashi T; Suzuki M; Matsunaga A; Saito T
Case Rep Nephrol Dial; 2015; 5(3):204-12. PubMed ID: 26955632
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of kidney transplantation in a patient with coexisting lipoprotein glomerulopathy and fibrillary glomerulonephritis.
Cheung CY; Chan AO; Chan GP; Iu HY; Shek CC; Chau KF
Clin Kidney J; 2014 Aug; 7(4):396-8. PubMed ID: 25852917
[TBL] [Abstract][Full Text] [Related]
13. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.
Han J; Pan Y; Chen Y; Li X; Xing G; Shi J; Hou P; Zhang H; Wang H
Nephron Clin Pract; 2010; 114(4):c260-7. PubMed ID: 20090368
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein glomerulopathy in China.
Chen Y
Clin Exp Nephrol; 2014 Apr; 18(2):218-9. PubMed ID: 24165683
[TBL] [Abstract][Full Text] [Related]
15. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Xie W; Xie Y; Lin Z; Xu X; Zhang Y
Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
[TBL] [Abstract][Full Text] [Related]
16. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H; Yang Y; Hu Z
J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
[TBL] [Abstract][Full Text] [Related]
17. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X
Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
